Lundbeck Inc. Company Profile

News Articles [ 315 Associated News Articles listed on BioPortfolio]

H. Lundbeck A/S: Lundbeck elects new chairman

H. Lundbeck A/S (Lundbeck) today announced that its Board of Directors will be electing a new chairman after the annual general meeting to be held on 21 March. Mats Pettersson, member of Lundbeck's...

Lundbeck: Abilify jetzt neu bei Lundbeck Austria

Lundbeck Austria ist seit April der lokale Vertreter für Abilify in Österreich. Lundbeck Austria hat damit auch die Verantwortung für die Vermarktung von Abilify von Bristol-Myers Squibb übernomme...

Vernalis plc and H.Lundbeck A/S Achieve Third Research Milestone

Vernalis plc today announces it has achieved a third milestone in its drug discovery collaboration with H.Lundbeck A/S (Lundbeck). Vernalis will receive a payment of £0.75m from Lundbeck in reco...

ImaginAb, Lundbeck in CNS antibody deal

Antibody company ImaginAb Inc. (Inglewood, Calif.) partnered with H. Lundbeck A/S (CSE:LUN) to reengineer an antibody against an undisclosed CNS target from Lundbeck for in vivo molecular imaging and...

H. Lundbeck A/S: Lundbeck introduces Selincro® as the first and only medicine for the reduction of alcohol consumption in alcohol dependent patients

Lundbeck launches Selincro® in Norway, Finland, Poland and the Baltic countries. Valby, 2013-04-22 08:00 CEST (GLOBE NEWSWIRE) -- H. Lundbeck A/S (Lundbeck) announced that the company shipped Selin.....

H. Lundbeck A/S: Full year report 2012 - Lundbeck delivers on guidance and sales of New Products increase more than 70%

H. Lundbeck A/S (Lundbeck) announces its financial results for 2012, which are in line with expectations for the year, excluding restructuring charges. Revenue for 2012 was DKK 14,227 million, excl...

H. Lundbeck A/S: Lundbeck is well on track to deliver on guidance for 2013

Valby, Denmark, 1 May 2013 - H. Lundbeck A/S (Lundbeck) reports first quarter revenue of DKK 4,576 million corresponding to an increase of 21%. Profit from operations (EBIT) in the quarter increase...

Lundbeck: Company Profile

Lundbeck, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years. Return to top 50 pharma list Summary Website: Lundbeck Headq...

Drugs and Medications [ 14 Associated Drugs and Medications listed on BioPortfolio]

Neoprofen [Lundbeck Inc.]

These highlights do not include all the information needed to use NeoProfen safely and effectively. See full prescribing information for NeoProfen. NeoProfen (ibuprofen lysine) Injection for intraveno...

Panhematin [Lundbeck Inc.]

Panhematin Hemin For Injection Rx only For intravenous infusion only.

Atryn [Lundbeck Inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Peganone [Lundbeck Inc.]

PEGANONE 250 mg Tablets (ethotoin tablets, USP) R Only

Cogentin [Lundbeck Inc.]

Cogentin® (benztropine mesylate injection) Rx only

PubMed Articles [ 25 Associated PubMed Articles listed on BioPortfolio]

What is effective when multicomponent interventions are applied to improve postoperative outcome?

Phosphodiesterase 10A inhibitors: a 2009 - 2012 patent update.

Introduction: Inhibitors of the phosphodiesterase enzyme PDE10A have been the target for extensive investigations and huge drug discovery research efforts during the recent years. Although PDE10A with...

Review of Classics in Stereoselective Synthesis Classics in Stereoselective Synthesis . Edited by E. M.Carreira and L.Kvaerno (ETH Zürich and H Lundbeck A/S, respectively). Wiley-VCH , Weinheim, Germany . 2009 . xix + 632 pp. 19 × 25 cm. €69.00 (soft

Complexation of tauro- and glyco-conjugated bile salts with α-cyclodextrin and hydroxypropyl-α-cyclodextrin studied by affinity capillary electrophoresis and molecular modelling.

The interaction of the bile salts taurocholate, taurodeoxycholate, taurochenodeoxycholate, glycocholate, glycodeoxycholate, and glycochenodeoxycholate present in man, dog, and rat with α-cyclodextrin...

In vitro, ex vivo and in vivo examination of buccal absorption of metoprolol with varying pH in TR146 cell culture, porcine buccal mucosa and Göttingen minipigs.

This work studied the buccal absorption of metoprolol in vitro, ex vivo and in vivo as a function of buffered pH at 7.4, 8.5, 9.0 and 9.5. Permeability studies showed a correlation (r(2)=0.92) between...

Clinical Trials [ 1 Associated Clinical Trials listed on BioPortfolio]

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

The purpose of this study is to investigate the utility of dopamine transporter imaging in monitoring and predicting the progression of Parkinson disease. This study will be performed in...

Companies [ 11 Associated Companies listed on BioPortfolio]

Lundbeck Inc.

Lundbeck Inc. was established in March 2009 following the acquisition of Ovation Pharmaceuticals, Inc. by Lundbeck and has proven success in developing and commercializing high-ne...

Lundbeck

Depression, schizophrenia, Alzheimer's, Parkinson's, epilepsy, Multiple Sclerosis, and migraines have their foundation in the Central Nervous System - our key focus areas. Lundbeck's entire R&D effort...

Psychotropics

The Lundbeck Institute is pleased to present Psychotropics Online, a comprehensive guide to CNS compounds and products.We have published Psychotropics since the 1960s in a printed handbook version, an...

Lundbeck Limited

As a pharmaceutical manufacturer, Lundbeck is unique in that we focus solely on the treatment of diseases of the central nervous system. Our aim is to be the world leader in the development of pharmac...

Lundbeck Pharma A/S

Nil